Nancy Lurker, President & CEO at EyePoint Pharmaceuticals, Inc. (EYPT), sold 10,000 shares at $20.15 ($202K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $202k EYPT by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EYPT | SELL | 2025-12-01 | $10K | — | Filing → |
| EYPT | BUY | 2024-08-20 | $25K | — | Filing → |
| EYPT | SELL | 2024-01-25 | $1.7M | — | Filing → |